Dental implant study: Same-Day placement works as well as waiting

NCT ID NCT02569671

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looked at whether placing a dental implant right after pulling a tooth works as well as waiting for the gum to heal first. Fifty-three adults with a single missing tooth in the front or premolar area received a Straumann implant either immediately or after healing. Researchers checked bone levels and implant success after one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

53 people

The number who actually took part.

Started

Mar 2016

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects must have voluntarily signed the informed consent form before any study related procedures * Subjects must be males or females who are a minimum of 18 years of age * Subjects who are in need of a single tooth extraction in the pre-molar or anterior region of the maxilla or mandible (ADA tooth positions 4-13 and 20-29) and replacement with a dental implant. * Implants must be placed either immediately in an extraction socket or placed in a healed site (greater than 4 months healing) which has not been previously grafted. * Planned site for implant must have a natural tooth both mesially and distally in the adjacent tooth positions * Subjects must have opposing dentition (natural teeth, fixed or removable restorations) * There must be sufficient bone at the implant site to achieve primary stability * Subjects must be committed to the study and the required follow-up visits * Subjects must be in good general health as assessed by the Investigator Exclusion Criteria: * Subjects with a systemic disease that would preclude dental implant surgery * Subjects with any contraindications for oral surgical procedures * Subjects with mucosal diseases (e.g., erosive lichen planus) in the localized area around the study implant site * Subjects with a history of local irradiation therapy in the head/neck area * Subjects with any untreated endodontic lesions or untreated periodontal disease adjacent to the implant site * Subjects receiving, or having a history of receiving, intravenous or subcutaneous antiresorptive agents, such as bisphosphonates * Subjects with severe bruxing, parafunctional habits, or temporomandibular joint dysfunction * Any implant sites where there will be a buccal dehiscence greater than 3 mm or there will be a fenestration of the implant * Subjects with inadequate oral hygiene or who are unmotivated for adequate home care * Subjects who have physical or mental handicaps that would interfere with the ability to perform adequate oral hygiene * Subjects who are pregnant or intending to become pregnant during the duration of the study * Subjects who are heavy smokers (defined as \>10 cigarettes per day or \>1 cigar per day) or chew tobacco * Subjects who abuse alcohol or drugs * Subjects who have undergone administration of any investigational device within 30 days of enrollment in the study * Subjects with conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Tooth loss are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Tooth Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center for Implant Dentistry, University of Florida

    Gainesville, Florida, 32610-0434, United States

  • UCLA School of Dentistry

    Los Angeles, California, 90095-1668, United States

  • University of Texas Health Science Center San Antonio

    San Antonio, Texas, 78229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.